Hormos Medical Corporation

Quatrx Pharmaceuticals Company

Schering Oy

Veli-Matti Lehtola

Markku Ahotupa

Mikko Unkila

Kaija Halonen

Markku Anttila

Helena Korte

Mervi Hiilovaara-Teijo

Eeva-Maria Susanne Rantala

Pertti Tapani Rantala

This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with a pharmaceutically acceptable carrier.

Oral formulations of ospemifene

This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.

Solid formulations of ospemifene

A topical formulation which includes a lignan or lignan ester in a dermatologically acceptable vehicle. The formulation can be either a cosmetic formulation or a pharmaceutical formulation.

Lignan formulations

Growing community of inventors

Turku, Finland

Veli-Matti Lehtola